"There is reason to wonder how the use of an obscure recombinant coagulation factor marketed exclusively to hematologists came to be used so widely by cardiac surgeons, neurologists and trauma specialists, " they said.

WSJ: Hemophilia Drug's Off-Label Use Is Faulted